AIC-CCMB aims to supports not just startups’ and innovators using Information Communication Technology (ICT) in healthcare through its MSH centre but other incubators as well. CSIR -CCMB is a globally renowned research institution working in the field human health and genomics and is poised to take up a leadership role in precision medicine. AIC-CCMB aims to leverage this strength and foster innovation in the areas of Machine Learning, Artificial Intelligence, IoT, Blockchain, Robotics etc in healthcare and related emerging areas to address societal challenges in ICTE areas.
Atal Incubation Center-CCMB (AIC-CCMB) is organizing an Ideathon to select best ideas to incubate under Technology Incubation and Development of Entrepreneurs Scheme(TIDE 2.0), supported by MeitY Startup Hub(MSH), Ministry of Electronics and Information Technology (MeitY), Government of India.
AIC-CCMB is inviting applications from individuals and companies aiming to address challenges in life sciences & healthcare by leveraging Information & Communication Technologies (ICT) including but not limited to AI, ML, Robotics, Block chain, AR, VR, IoT in medical devices and diagnostics.
Application of ICT & other emerging technologies in life sciences & healthcare.
Potential areas of work:
AI leading to Precision medicine
Medical Imaging for diagnosis and clinical assistance
High-performance medicine propelled by data analytics
Computer vision for augmented medicine
Leveraging Bioinformatics, NLP & genomic sequencing to diagnose diseases and strengthen personalized medicine
IoT models for Organ on Chip, Smart wearables, IoT based medical devices and diagnostics
Robotic solutions for prosthetics
ICT based innovations to tackle covid-19 challenges, animal healthcare etc.
All the proposals shall be considered by a Management Committee (MC) constituted by AIC-CCMB. Only the proposals approved by the MC shall be allowed access to the facility and undertake project work on the agreed terms and conditions for development of innovative products and processes.